Neumora

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Neumora 是一家在股票代码 NMR (US) 下上市的公司。

涉及Neumora的并购和融资。

• Neumora 刚刚宣布为 250 筹款数百万美元。 (公布2023九月18号).

查看带有其 22 名主要高管的组织结构图

Neumora 搜索最多的简介

• Henry Gosebruch, President, Chief Executive Officer and Director (...
• Paul Berns, Chairman of the Board and Chief Executive Officer
• David Piacquad, Director

高管在Neumora变化

• Carol Suh 曾任 Chief Operating Officer, 现升职为 Chief Operating and Development Officer  (新闻发布的2025二月13号).
• Joshua Pinto 曾任 Chief Financial Officer, 现升职为 President  (新闻发布的2025二月13号).
• Michael Milligan 曾任 Senior Vice President, Finance and Principal Accounting Officer, 现升职为 Chief Financial Officer  (新闻发布的2025二月13号).

更多的变化在％s

创建提醒
跟踪 Neumora 的高管变动

Neumora 拥有 2,347 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• Bristol-Myers Squibb has announced the acquisition of 2Seventy Bio  (公布2025三月11号).
• Callio Therapeutics 刚刚宣布为 187 筹款数百万美元。 (公布2025三月7号).
• Eikon Therapeutics 刚刚宣布为 351 筹款数百万美元。 (公布2025二月27号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• VBI Vaccines 企业 Steven Gillis - Chairman of the Board
• UroGen 企业 Fred Cohen - Director

了解更多有关生物技术行业的信息 >

Neumora 的最新新闻稿

• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Brain disease startup Neumora draws more funding for ambitious research plan
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases - Neumora
• Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases - Neumora
• Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University - Neumora
• View more press releases Close

关于 Neumora 的社交媒体

• Neumora 在 维基百科、谷歌新闻 和 雅虎财经
• Neumora 在 LinkedIn、叽叽喳喳 和 YouTube